Brian E. Fink
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 5%
- Synthesis and biological activity
Papers in
-
- Chemical Synthesis and Analysis 8
- DNA and Nucleic Acid Chemistry 3
- Advanced biosensing and bioanalysis techniques 2
- Oncology 14
- HER2/EGFR in Cancer Research 9
- Co-authors
- Michael P. Hedrick (5 shared papers)Dale L. Boger (5 shared papers)S.R. Brunette (1 shared paper)Winston C. Tse (1 shared paper)John A. Katzenellenbogen (3 shared papers)Ramji R. Rajendran (1 shared paper)Benita S. Katzenellenbogen (1 shared paper)Jun Sun (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of the American Chemical Society (3 papers)Clinical Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)The Prostate (1 paper)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Brian E. Fink
27 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 89
- Toxicology 109
- Organic Chemistry 687
- Oncology 426
- Molecular Biology 893
- Genetics 357
Countries citing papers authored by Brian E. Fink
This map shows the geographic impact of Brian E. Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian E. Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian E. Fink more than expected).
Fields of papers citing papers by Brian E. Fink
This network shows the impact of papers produced by Brian E. Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian E. Fink. The network helps show where Brian E. Fink may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian E. Fink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 493 | |
| 2 | 1999 | 273 | |
| 3 | 1999 | 195 | |
| 4 | 2000 | 166 | |
| 5 | 1998 | 88 | |
| 6 | 2004 | 78 | |
| 7 | 2006 | 65 | |
| 8 | 2005 | 37 | |
| 9 | 2006 | 36 | |
| 10 | 2001 | 30 | |
| 11 | 2000 | 25 | |
| 12 | 2010 | 23 | |
| 13 | 2005 | 22 | |
| 14 | 2007 | 19 | |
| 15 | 2011 | 18 | |
| 16 | 2000 | 17 | |
| 17 | 2019 | 17 | |
| 18 | 1995 | 12 | |
| 19 | 2006 | 12 | |
| 20 | 2008 | 10 |
About Brian E. Fink
Brian E. Fink is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 27 papers that have together received 1.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Chemical Synthesis and Analysis (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Synthetic Organic Chemistry Methods (3 papers), DNA and Nucleic Acid Chemistry (3 papers), Estrogen and related hormone effects (3 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Quinazolinone synthesis and applications (2 papers). The work is most often cited by research in Toxicology (109 citations), Organic Chemistry (687 citations), Oncology (426 citations), Molecular Biology (893 citations) and Genetics (357 citations). Brian E. Fink has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Michael P. Hedrick, Dale L. Boger, S.R. Brunette, Winston C. Tse, John A. Katzenellenbogen, Ramji R. Rajendran, Benita S. Katzenellenbogen, Jun Sun, Marvin J. Meyers and Shaun R. Stauffer. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of the American Chemical Society, Clinical Cancer Research, Molecular Cancer Therapeutics and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.